25-hydroxyvitamin D Testing in Children and Adolescents

This policy covers measurement of 25‑hydroxyvitamin D (25‑OH‑D) concentration for screening and evaluation of vitamin D status in children and adolescents identified as high‑risk—including those with conditions associated with reduced bone mass, recurrent low‑impact fractures, multiple risk factors for deficiency, or pediatric obesity (BMI ≥95th percentile). Testing is not medically necessary for healthy, asymptomatic children and adolescents (including obese but otherwise healthy patients), the 1,25‑dihydroxyvitamin D assay is not recommended for deficiency screening, and coverage is subject to coding rules and applicable plan, Medicaid, and Medicare requirements and limitations.

"Measurement of 25-hydroxyvitamin D (25-OH-D) concentration is appropriate for screening for vitamin D deficiency."

Sign up to see full coverage criteria, indications, and limitations.